In AD, the downregulation of EAAT1 and EAAT2 expression in astrocytes leads to the accumulation of extracellular glutamate, promoting excitotoxicity and consequent neuronal impairment [113]. This evidence concerns the gene SLC1A2 and Alzheimer disease.